Genetic association studies: genes in search of diseases.

PubWeight™: 1.65‹?› | Rank: Top 3%

🔗 View Article (PMID 11591829)

Published in Neurology on October 09, 2001

Authors

T D Bird, G P Jarvik, N W Wood

Articles by these authors

(truncated to the top 100)

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med (1996) 10.44

Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27

Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol (1998) 5.42

Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med (2000) 4.98

DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell (1993) 4.57

An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8) Nat Genet (1999) 4.15

Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science (1998) 4.07

Research ethics. Research practice and participant preferences: the growing gulf. Science (2011) 3.27

A familial Alzheimer's disease locus on chromosome 1. Science (1995) 3.14

Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science (1992) 3.14

Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet (2005) 2.56

PINK1 protein in normal human brain and Parkinson's disease. Brain (2006) 2.49

The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective. JAMA (1997) 2.45

A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Hum Mol Genet (1999) 2.41

Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc Natl Acad Sci U S A (1999) 2.26

The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet (2000) 2.24

Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet (1997) 2.16

Neural transplantation in Huntington disease: long-term grafts in two patients. Neurology (2007) 2.15

Clinical and laboratory findings in referrals for mitochondrial DNA analysis. Arch Dis Child (1998) 2.12

Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type. J Neurogenet (1987) 2.12

Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet (1999) 2.12

Late-onset hereditary axonal neuropathies. Neurology (2008) 2.09

Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nat Genet (1993) 2.07

Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol (1998) 1.93

Alzheimer's disease, apolipoprotein E4, and gender. JAMA (1994) 1.86

Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet (2001) 1.85

A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain (1999) 1.84

Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol (2001) 1.84

Beta-synuclein gene alterations in dementia with Lewy bodies. Neurology (2004) 1.82

Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females. Hum Mol Genet (2001) 1.80

Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol (1998) 1.80

Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol (1998) 1.79

Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nat Genet (1997) 1.79

Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation. Neurology (2005) 1.77

Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology (2000) 1.76

The clinical and genetic spectrum of spinocerebellar ataxia 14. Neurology (2005) 1.74

Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology (2003) 1.74

Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred. Ann Neurol (1994) 1.73

Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet (2001) 1.72

Evidence for linkage of Charcot-Marie-Tooth neuropathy to the Duffy locus on chromosome 1. Am J Hum Genet (1982) 1.69

A conserved sorting-associated protein is mutant in chorea-acanthocytosis. Nat Genet (2001) 1.69

Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25. Am J Hum Genet (1997) 1.68

Understanding the molecular causes of Parkinson's disease. Trends Mol Med (2006) 1.62

Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology (1998) 1.62

The British Isles survey of multiple sclerosis in twins. Neurology (1994) 1.57

MR imaging of adventitial vasa vasorum in carotid atherosclerosis. Magn Reson Med (2008) 1.57

Tau gene and Parkinson's disease: a case-control study and meta-analysis. J Neurol Neurosurg Psychiatry (2004) 1.56

Late-onset SCA2: 33 CAG repeats are sufficient to cause disease. Neurology (2000) 1.56

The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors. Brain (1999) 1.56

Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet (2002) 1.56

Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet (1996) 1.54

Dandy-Walker malformation: etiologic heterogeneity and empiric recurrence risks. Clin Genet (1985) 1.52

Charcot-Marie-Tooth disease: data for genetic counseling relating age to risk. Clin Genet (1978) 1.51

A familial neuronal disease presenting as intestinal pseudoobstruction. Gastroenterology (1978) 1.50

PINK1 (PARK6) associated Parkinson disease in Ireland. Neurology (2004) 1.49

Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy. Ann Neurol (2000) 1.47

Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J Neurol Neurosurg Psychiatry (2009) 1.46

Polymorphisms in the human paraoxonase (PON1) promoter. Pharmacogenetics (2001) 1.46

The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain (2001) 1.44

Theophylline-associated seizures with "therapeutic" or low toxic serum concentrations: risk factors for serious outcome in adults. Neurology (1991) 1.44

Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response. Cell Death Differ (2008) 1.44

Absence of linkage of chromosome 21q21 markers to familial Alzheimer's disease. Science (1988) 1.44

Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nat Genet (1992) 1.43

A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology. Brain (2007) 1.40

Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet (1996) 1.38

Multiple sclerosis in the Cambridge health district of east Anglia. J Neurol Neurosurg Psychiatry (1992) 1.33

Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43). Ann Neurol (1996) 1.32

Analysis of chromosome 1q42.2-43 in 152 families with high risk of prostate cancer. Am J Hum Genet (1999) 1.30

Apolipoprotein E genotype and Alzheimer's disease. Lancet (1993) 1.30

Genetic linkage evidence for heterogeneity in Charcot-Marie-Tooth neuropathy (HMSN type I). Ann Neurol (1983) 1.30

Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease. Am J Hum Genet (1991) 1.28

A second paroxysmal kinesigenic choreoathetosis locus (EKD2) mapping on 16q13-q22.1 indicates a family of genes which give rise to paroxysmal disorders on human chromosome 16. Brain (2000) 1.27

Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology (2009) 1.26

Hereditary motor and sensory neuropathy with diaphragm and vocal cord paresis. Ann Neurol (1994) 1.26

Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol (1998) 1.25

The alpha-synuclein gene in multiple system atrophy. J Neurol Neurosurg Psychiatry (2006) 1.25

Genetic linkage and heterogeneity in type I Charcot-Marie-Tooth disease (hereditary motor and sensory neuropathy type I). Am J Hum Genet (1990) 1.24

Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins. Neurology (1998) 1.24

Anticipation in familial leukemia. Am J Hum Genet (1996) 1.23

Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. Am J Pathol (2001) 1.20

Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia. Neurology (1998) 1.19

Trinucleotide repeats and neurodegenerative disease. Brain (2004) 1.19

Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A. Cancer (1996) 1.19

Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala. Neurology (1992) 1.18

Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: a cautionary view. Ann Neurol (1995) 1.18

The porphyria, plumbism, pottery puzzle. JAMA (1982) 1.18

SCA8 CTG repeat: en masse contractions in sperm and intergenerational sequence changes may play a role in reduced penetrance. Hum Mol Genet (2000) 1.17

Spinocerebellar ataxia type 1 and Machado-Joseph disease: incidence of CAG expansions among adult-onset ataxia patients from 311 families with dominant, recessive, or sporadic ataxia. Am J Hum Genet (1995) 1.17

The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group. Brain (2005) 1.14

Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology (2008) 1.14

A novel TRK A (NTRK1) mutation associated with hereditary sensory and autonomic neuropathy type V. Ann Neurol (2001) 1.14

Hazardous lead release from glazed dinnerware: a cautionary note. Sci Total Environ (1985) 1.14

Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families. Neurology (1998) 1.14

Transmission and age-at-onset patterns in familial Alzheimer's disease: evidence for heterogeneity. Neurology (1990) 1.13

Multiple system atrophy/progressive supranuclear palsy: alpha-Synuclein, synphilin, tau, and APOE. Neurology (2000) 1.13

The role of DYT1 in primary torsion dystonia in Europe. Brain (1998) 1.13

Cognitive and personality function in myotonic muscular dystrophy. J Neurol Neurosurg Psychiatry (1983) 1.13

Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. Ann Neurol (2000) 1.12

Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia. Arch Neurol (2001) 1.11